Biologics & Biosimilars

EULAR 2013: Drugs New and Old Could Treat Spondylarthropies

September 1, 2013 • By Thomas R. Collins

When Will Generic Biologic Drugs Become Commercially Available?

August 1, 2013 • By Vibke Strand, MD, and Richard Brasington, MD

Tofacitinib and Other Kinase Inhibitors Offer New Approach to Treating Rheumatoid Arthritis

June 1, 2013 • By Deborah L. Parks, MD

Rheumatology Drug Updates: Apremilast, Golimumab, and More

November 1, 2012 • By Michele B. Kaufman, PharmD, BCGP

Drug Updates: Lorcaserin, Acetaminophen, and More

September 5, 2012 • By Michele B. Kaufman, PharmD, BCGP

EULAR 2012: Remission the New Normal for Rheumatoid Arthritis

August 8, 2012 • By Thomas R. Collins

American College of Rheumatology Leads Charge to Address Excessive Patient Cost Sharing

August 8, 2012 • By Staff

Managing an In-Office Infusion Practice

August 8, 2012 • By Staff

Drug Updates: EULAR 2012

August 8, 2012 • By Michele B. Kaufman, PharmD, BCGP

Drug Updates

July 9, 2012 • By Michele B. Kaufman, PharmD, BCGP